Database : MEDLINE
Search on : adrenal and gland and neoplasms [Words]
References found : 24855 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 2486 go to page                         

  1 / 24855 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 29397600
[Au] Autor:Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
[Ad] Address:Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
[Ti] Title:[A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
[So] Source:Zhonghua Nei Ke Za Zhi;57(2):134-137, 2018 Feb 01.
[Is] ISSN:0578-1426
[Cp] Country of publication:China
[La] Language:chi
[Ab] Abstract:Multiple endocrine neoplasia type 2A (MEN2A) is a hereditary syndrome. Here, two different RET proto-oncogen mutation were identified from family members of two MEN2A pedigrees by genetic screening. One RET mutations were found at codons 1893 and 1895 in exon 11 (1893-1895delCGA) from pedigree 1, which is a novel mutation, the other occurs at codon 634 (Cys634Arg) in exon 11 from pedigree 2. However, the clinical characteristics were similar in the patients of the two pedigrees. All the patients were in middle-age at onset. Most of them were firstly diagnosed with bilateral adrenal pheochromocytoma with different degrees of thyroid abnormalities (elevated serum calcitonin with or without thyroid mass, or had been diagnosed with medullary thyroid carcinoma). Some family members were with elevated serum parathyroid hormone but with no other evidences for hyperparathyroidism.
[Mh] MeSH terms primary: Adrenal Gland Neoplasms/diagnosis
Multiple Endocrine Neoplasia Type 2a/genetics
Mutation
Pheochromocytoma/diagnosis
Proto-Oncogene Proteins c-ret/genetics
[Mh] MeSH terms secundary: Adrenal Gland Neoplasms/genetics
Carcinoma, Neuroendocrine/diagnosis
Carcinoma, Neuroendocrine/genetics
Exons
Humans
Middle Aged
Multiple Endocrine Neoplasia Type 2a/pathology
Pedigree
Pheochromocytoma/genetics
Point Mutation
Thyroid Neoplasms/diagnosis
Thyroid Neoplasms/genetics
[Pt] Publication type:COMPARATIVE STUDY; JOURNAL ARTICLE
[Nm] Name of substance:EC 2.7.10.1 (Proto-Oncogene Proteins c-ret)
[Em] Entry month:1803
[Cu] Class update date: 180306
[Lr] Last revision date:180306
[Js] Journal subset:IM
[Da] Date of entry for processing:180206
[St] Status:MEDLINE
[do] DOI:10.3760/cma.j.issn.0578-1426.2018.02.010

  2 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29348269
[Au] Autor:Hanna FWF; Issa BG; Sim J; Keevil B; Fryer AA
[Ad] Address:Staffordshire University, University Hospital of North Midlands, Stoke-on-Trent, UK Fahmy.hanna@uhns.nhs.uk.
[Ti] Title:Management of incidental adrenal tumours.
[So] Source:BMJ;360:j5674, 2018 01 18.
[Is] ISSN:1756-1833
[Cp] Country of publication:England
[La] Language:eng
[Mh] MeSH terms primary: Adrenal Gland Neoplasms/therapy
Disease Management
Practice Guidelines as Topic
[Mh] MeSH terms secundary: Adrenal Gland Neoplasms/blood
Adrenal Gland Neoplasms/diagnostic imaging
Catecholamines/blood
Glucocorticoids/blood
Humans
Mineralocorticoids/blood
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Catecholamines); 0 (Glucocorticoids); 0 (Mineralocorticoids)
[Em] Entry month:1803
[Cu] Class update date: 180306
[Lr] Last revision date:180306
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180120
[St] Status:MEDLINE
[do] DOI:10.1136/bmj.j5674

  3 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29319371
[Au] Autor:Nieder C; Tollåli T; Haukland E; Reigstad A; Randi Flatøy L; Dalhaug A
[Ad] Address:a Departments of Oncology and Palliative Medicine , Nordland Hospital Trust , Bodø , Norway.
[Ti] Title:A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.
[So] Source:Cancer Invest;36(1):59-65, 2018 Jan 02.
[Is] ISSN:1532-4192
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:Palliative radiotherapy improves lung cancer related symptoms. Prognosis should be taken into account when deciding about fractionation. In this study, prognostic factors derived from multivariate analysis were used to assign a point sum reflecting 6-month survival. Four prognostic groups were compared. Performance status, lactate dehydrogenase, C-reactive protein, liver/adrenal gland metastases, and extrathoracic disease status significantly predicted survival and formed the basis of the score. The four groups had a median survival of 0.8, 1.6, 3.3, and 10.5 months (6-month survival 0, 10, 30, 70%; 12-month survival 0, 0, 12, 40%; p = 0.0001), respectively. In the unfavorable group best supportive care might be preferable.
[Mh] MeSH terms primary: Lung Neoplasms/pathology
Lung Neoplasms/radiotherapy
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
C-Reactive Protein/metabolism
Dose Fractionation
Female
Humans
L-Lactate Dehydrogenase/metabolism
Lung Neoplasms/metabolism
Male
Middle Aged
Multivariate Analysis
Neoplasm Metastasis/pathology
Neoplasm Metastasis/radiotherapy
Palliative Care/methods
Prognosis
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:9007-41-4 (C-Reactive Protein); EC 1.1.1.27 (L-Lactate Dehydrogenase)
[Em] Entry month:1803
[Cu] Class update date: 180305
[Lr] Last revision date:180305
[Js] Journal subset:IM
[Da] Date of entry for processing:180111
[St] Status:MEDLINE
[do] DOI:10.1080/07357907.2017.1416394

  4 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29406048
[Au] Autor:Chaaya G; Morales J; Castiglioni A; Subhani N; Asmar A
[Ad] Address:University of Central Florida College of Medicine, Orlando, Florida.
[Ti] Title:Paraganglioma of the Urinary Bladder: A Rare Cause of Hypertension and Urinary Tract Infections.
[So] Source:Am J Med Sci;355(2):191-194, 2018 Feb.
[Is] ISSN:1538-2990
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:Pheochromocytoma is a neoplasm, which develops from cells of the chromaffin tissues that are derived from the ectodermic neural system and mostly situated within the adrenal medulla. Approximately 15% of pheochromocytoma cases arise from extra-adrenal chromaffin tissue. Pheochromocytoma of the bladder is rare and accounts for less than 0.06% of all bladder neoplasms and less than 1% of all pheochromocytomas. We report a case of a young woman who presented with uncontrolled hypertension, recurrent urinary tract infections and micturition attacks and was found to have a metastatic bladder paraganglioma. In addition, we provide a summary table of the clinical manifestations of paragangliomas based on anatomic locations.
[Mh] MeSH terms primary: Adrenal Gland Neoplasms
Hypertension
Urinary Bladder Neoplasms
Urinary Tract Infections
[Mh] MeSH terms secundary: Adrenal Gland Neoplasms/microbiology
Adrenal Gland Neoplasms/pathology
Adrenal Gland Neoplasms/physiopathology
Adult
Female
Humans
Hypertension/microbiology
Hypertension/pathology
Hypertension/physiopathology
Neoplasm Metastasis
Pheochromocytoma/microbiology
Pheochromocytoma/pathology
Pheochromocytoma/physiopathology
Pheochromocytoma/secondary
Urinary Bladder Neoplasms/microbiology
Urinary Bladder Neoplasms/pathology
Urinary Bladder Neoplasms/physiopathology
Urinary Tract Infections/microbiology
Urinary Tract Infections/pathology
Urinary Tract Infections/physiopathology
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1803
[Cu] Class update date: 180301
[Lr] Last revision date:180301
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180207
[St] Status:MEDLINE

  5 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 28471119
[Au] Autor:Dai J; Chen SJ; Yang BS; Lü SM; Zhu M; Xu YF; Chen J; Cai HW; Mao W
[Ad] Address:Department of Cardiology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou 310006, China.
[Ti] Title:Recurrence of non-cardiogenic pulmonary edema and sustained hypotension shock in cystic pheochromocytoma.
[So] Source:J Zhejiang Univ Sci B;18(5):449-452, 2017 May.
[Is] ISSN:1862-1783
[Cp] Country of publication:China
[La] Language:eng
[Ab] Abstract:Pheochromocytoma is a rare neuroendocrine tumor which derives from chromaffin cells of the adrenal gland or relevant to sympathetic nerves and ganglia. The clinical features of pheochromocytoma are various. Paroxysmal episodes of serious hypertension, headache, palpitation, and diaphoresis are the typical manifestations (Bravo, 2004). Hypotension shock, pulmonary edema, and acute coronary syndrome induced by pheochromocytoma are uncommon (Malindretos et al., 2008; Batisse-Lignier et al., 2015). In this study, we present a rare case of cystic pheochromocytoma causing recurrent hypotension shock, non-cardiogenic pulmonary edema, and acute coronary syndrome, and the possible mechanisms are discussed.
[Mh] MeSH terms primary: Adrenal Gland Neoplasms/complications
Adrenal Gland Neoplasms/diagnosis
Pheochromocytoma/complications
Pheochromocytoma/diagnosis
Pulmonary Edema/diagnosis
Pulmonary Edema/etiology
Shock/etiology
[Mh] MeSH terms secundary: Adrenal Gland Neoplasms/therapy
Cysts/complications
Cysts/diagnosis
Cysts/therapy
Diagnosis, Differential
Female
Humans
Hypotension/diagnosis
Hypotension/etiology
Hypotension/therapy
Middle Aged
Pheochromocytoma/therapy
Pulmonary Edema/therapy
Recovery of Function
Recurrence
Shock/diagnosis
Shock/prevention & control
Treatment Outcome
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180226
[Lr] Last revision date:180226
[Js] Journal subset:IM
[Da] Date of entry for processing:170505
[St] Status:MEDLINE
[do] DOI:10.1631/jzus.B1600411

  6 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 29374711
[Au] Autor:Jung J; Seo J; Kim J; Kim JH
[Ad] Address:Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
[Ti] Title:Ursolic Acid Causes Cell Death in PC-12 Cells by Inducing Apoptosis and Impairing Autophagy.
[So] Source:Anticancer Res;38(2):847-853, 2018 02.
[Is] ISSN:1791-7530
[Cp] Country of publication:Greece
[La] Language:eng
[Ab] Abstract:Ursolic acid (UA) is a natural pentacyclic triterpene that has various biological activities, including anticancer and anti-inflammatory effects. This study investigated the ability of UA to cause cell death in pheochromocytoma (PC-12) cells. UA was cytotoxic to PC-12 cells (half-maximum inhibitory concentration=53.2 µM) and significantly reduced the clonogenic ability of PC-12 cells. It also triggered apoptosis by reducing the level of B-cell lymphoma 2 (BCL2), activating caspase-3, and inducing cleavage of poly (ADP-ribosyl) polymerase. To investigate the effects of UA treatment on the induction and progression of autophagy, the levels of p62 and the conversion of the microtubule-associated protein light chain 3 (LC3)-I to LC3-II, which are important markers of autophagic flux, were monitored. UA treatment induced the accumulation of p62 and increased the LC3-II/LC3-I ratio. These results demonstrate that UA treatment induced autophagy, but the downstream signaling pathway was blocked. In summary, this study shows that UA kills PC-12 cells by inducing apoptosis and impairing autophagy progression.
[Mh] MeSH terms primary: Adrenal Gland Neoplasms/drug therapy
Adrenal Gland Neoplasms/pathology
Apoptosis/drug effects
Autophagy/drug effects
Pheochromocytoma/drug therapy
Pheochromocytoma/pathology
Triterpenes/pharmacology
[Mh] MeSH terms secundary: Animals
Antineoplastic Agents, Phytogenic/pharmacology
Apoptosis/physiology
Autophagy/physiology
Cell Proliferation/drug effects
PC12 Cells
Rats
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Antineoplastic Agents, Phytogenic); 0 (Triterpenes); P3M2575F3F (ursolic acid)
[Em] Entry month:1802
[Cu] Class update date: 180221
[Lr] Last revision date:180221
[Js] Journal subset:IM
[Da] Date of entry for processing:180129
[St] Status:MEDLINE

  7 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29390437
[Au] Autor:Yoshiji S; Shibue K; Fujii T; Usui T; Hirota K; Taura D; Inoue M; Sone M; Yasoda A; Inagaki N
[Ad] Address:Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto.
[Ti] Title:Chronic primary adrenal insufficiency after unilateral adrenonephrectomy: A case report.
[So] Source:Medicine (Baltimore);96(51):e9091, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:RATIONALE: Unilateral adrenalectomy as part of surgical resection of renal cell carcinoma (RCC) is not thought to increase the risk of chronic adrenal insufficiency, as the contralateral adrenal gland is assumed to be capable of compensating for the lost function of the resected gland. However, recent studies have indicated that adrenalectomy might cause irreversible impairment of the adrenocortical reserve. We describe a case of chronic primary adrenal insufficiency in a 68-year-old man who previously underwent unilateral adrenonephrectomy, which was complicated by severe postoperative adrenal stress that involved cardiopulmonary disturbance and systemic infection. PATIENT CONCERNS: A 68-year-old Japanese man presented with weight loss of 6 kg over a 4-month period, and renal biopsy confirmed a diagnosis of RCC. He underwent adrenonephrectomy for the RCC, but developed postoperative septic shock because of a retroperitoneal cystic infection and ventricular fibrillation that was induced by vasospastic angina. The patient was successfully treated using antibiotics and percutaneous coronary intervention, and was subsequently discharged with no apparent complications except decreased appetite and general fatigue. However, his appetite and fatigue did not improve over time and he was readmitted for an examination. DIAGNOSES: The workup revealed a markedly elevated adrenocorticotropic hormone (ACTH) level (151.4 pg/mL, normal: 7-50 pg/mL) and a mildly decreased morning serum cortisol level (6.4 mg/mL, normal: 7-28 mg/mL). In addition to the patient's clinical symptoms and laboratory results, the results from ACTH and corticotropin-releasing hormone stimulation tests were used to make a diagnosis of primary adrenal insufficiency. INTERVENTIONS: Treatment was initiated using oral prednisolone (20 mg), which rapidly resolved his symptoms. At the 1-year follow-up, the patient had a markedly decreased serum cortisol level (2.0 mg/mL) with an ACTH level that was within the normal range (44.1 pg/mL) before his morning dose of prednisolone, which confirmed the diagnosis of chronic primary adrenal insufficiency. LESSONS: Clinicians must be aware of chronic adrenal insufficiency as a possible complication of unilateral adrenalectomy, especially when patients who underwent unilateral adrenalectomy experience severe adrenal stress.
[Mh] MeSH terms primary: Addison Disease/etiology
Adrenalectomy/adverse effects
Nephrectomy/adverse effects
[Mh] MeSH terms secundary: Addison Disease/diagnosis
Addison Disease/drug therapy
Aged
Carcinoma, Renal Cell/surgery
Glucocorticoids/therapeutic use
Humans
Hydrocortisone/blood
Kidney Neoplasms/surgery
Male
Prednisolone/therapeutic use
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Nm] Name of substance:0 (Glucocorticoids); 9PHQ9Y1OLM (Prednisolone); WI4X0X7BPJ (Hydrocortisone)
[Em] Entry month:1802
[Cu] Class update date: 180220
[Lr] Last revision date:180220
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009091

  8 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29390427
[Au] Autor:Xu B; Hong Y; Jin M; Li M; Wang C; Wang X
[Ad] Address:Department of Urology.
[Ti] Title:Primary adrenal malignant melanoma: A case report and review of literature.
[So] Source:Medicine (Baltimore);96(51):e8956, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:RATIONALE: The primary adrenal melanoma (PAM) was an extremely rare occurrence, which was demonstrated as the few cases described in the medical literature. PATIENT CONCERNS: We reported a 58-year-old man who was admitted to hospital because of intermittent left flank pain which lasted for a month. The renal computed tomography (CT) scan showed that a large retroperitoneal tumor measuring 15.5 cm × 12.1 cm × 13.0 cm seemed to have its origin in the left adrenal gland. DIAGNOSES: According to clinical symptoms, previous history, physical examination, and postoperative pathology, the patient was diagnosed as PAM. INTERVENTIONS: The patient was treated with an open procedure for resection of retroperitoneal tumor. After the surgery, the patient participated in the clinical drug trial and received treatment with ipilimumab as adjuvant medical therapy. OUTCOMES: When this article was completed, the patient was still alive and the survival has been already up to 20 months. LESSONS: The PAM was extremely rare in clinic, and its diagnosis and differential diagnosis were difficult. Therefore, clinical physicians should attach great importance to this disease.
[Mh] MeSH terms primary: Adrenal Gland Neoplasms/diagnosis
Lung Neoplasms/diagnosis
Melanoma/diagnosis
[Mh] MeSH terms secundary: Adrenal Gland Neoplasms/diagnostic imaging
Adrenal Gland Neoplasms/pathology
Adrenal Gland Neoplasms/therapy
Combined Modality Therapy
Diagnosis, Differential
Humans
Lung Neoplasms/diagnostic imaging
Lung Neoplasms/secondary
Lung Neoplasms/therapy
Male
Melanoma/diagnostic imaging
Melanoma/secondary
Melanoma/therapy
Middle Aged
Neoplasm Metastasis
Tomography, X-Ray Computed
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180213
[Lr] Last revision date:180213
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000008956

  9 / 24855 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 29390591
[Au] Autor:Kan HC; Pang ST; Wu CT; Chang YH; Liu CY; Chuang CK; Lin PH
[Ad] Address:Department of Surgery, Division of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan.
[Ti] Title:Robot-assisted laparoendoscopic single site adrenalectomy: A comparison of 3 different port platforms with 3 case reports.
[So] Source:Medicine (Baltimore);96(51):e9479, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:RATIONALE: Laparoscopic adrenalectomy is currently the standard of care for adrenal lesion. Minimal invasive laparoscopic surgery such as laparoendoscopic single site surgery (LESS) and natural orifice transluminal endoscopic surgery (NOTES) have been developed to improve cosmetic outcomes and reduce postoperative pain. However, there are still some problems related to instruments and port limitation during LESS surgery. Robot-assisted laparoscopic surgery may help to overcome these problems, and port platforms selection is an important issue. PATIENT CONCERNS: Three cases received robot-assisted LESS adrenalectomy due to adrenal tumor were enrolled. Blood loss, hospital stay, and analgesia injection were compared. DIAGNOSES: Preoperative evaluations were done in a usual manner. Benign tumors were suspect for two patients, while metastatic tumor could not be excluded for the other patient with prior malignancy history. The pathology reports were all benign adrenal cortical adenoma after operation. INTERVENTIONS: Three different port platforms, Da Vinci Single-Site Surgical Platform, GelPOINT, and homemade glove port were used. Trans-peritoneal approach was used for two patients, while the other one received trans-retroperitoneal approach. The advantage and disadvantage of different port platforms were discussed. OUTCOMES: All patients underwent the operation smoothly without major complications or conversion to open surgery. Blood loss amount was small, hospital stay was short, and only one patient received one single dose of opioid analgesia injection after the surgery. LESSONS: The main problems of LESS are the loss of a working triangle and the limitations of the instruments. Robot-assisted LESS may help surgeons overcome part of these problems. Many different port platforms are available, and based on our initial experience, we believe that the GelPoint may be a more suitable platform, for it maintains the endo-wrist function of the Da Vinci instruments, and allows the surgeon to design the position of ports freely to minimize external and internal collision.
[Mh] MeSH terms primary: Adrenalectomy/methods
Robotic Surgical Procedures/methods
[Mh] MeSH terms secundary: Adenoma/surgery
Adrenal Gland Neoplasms/surgery
Adrenalectomy/instrumentation
Adult
Aged
Female
Humans
Male
Middle Aged
Robotic Surgical Procedures/instrumentation
[Pt] Publication type:CASE REPORTS; COMPARATIVE STUDY; JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180212
[Lr] Last revision date:180212
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009479

  10 / 24855 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 29384929
[Au] Autor:Park SY; Kwak MK; Kim HJ; Park HK; Suh KI; Yoo MH; Jin SY; Yun S; Byun DW
[Ad] Address:Division of Endocrinology and Metabolism, Departments of Internal Medicine.
[Ti] Title:Case report of a bilateral adrenal myelolipoma associated with Cushing disease.
[So] Source:Medicine (Baltimore);96(52):e9455, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:RATIONALE: Adrenal myelolipomas are rare benign tumors, composed of a variable mixture of mature adipose tissue and hematopoietic tissue. These tumors are frequently detected incidentally and are usually asymptomatic, and hormonally inactive. PATIENT CONCERNS: During a routine health checkup, a 52-year-old man was found to have a tumor on the bilateral adrenal glands. Abdominal computed tomography revealed a well-defined, heterogeneously enhanced bilateral adrenal mass, suggesting a myelolipoma. DIAGNOSES: The hormonal evaluation revealed adrenocorticotropic hormone (ACTH) dependent Cushing syndrome. INTERVENTIONS: The patient underwent left adrenalectomy, and transsphenoidal resection of a pituitary mass. The final diagnosis was adrenal myelolipoma associated with Cushing disease. OUTCOMES: Growth of right adrenal myelolipoma was detected during the 7-year follow-up. There were enhancing pituitary lesions in repeat magnetic resonance imaging of the sellar region, which implies persistent or recurrent pituitary adenoma. This case reinforces relationship between Cushing disease and adrenal myelolipoma. LESSONS: To the best of our knowledge, this is the first reported pathologically confirmed bilateral adrenal myelolipoma associated with Cushing disease. This report supports the idea that ACTH is associated with the development of adrenal myelolipoma.
[Mh] MeSH terms primary: Adrenal Gland Neoplasms/complications
Adrenal Gland Neoplasms/diagnosis
Myelolipoma/complications
Myelolipoma/diagnosis
Pituitary ACTH Hypersecretion/complications
Pituitary ACTH Hypersecretion/diagnosis
[Mh] MeSH terms secundary: Adrenal Gland Neoplasms/surgery
Adrenalectomy
Humans
Male
Middle Aged
Myelolipoma/surgery
Pituitary ACTH Hypersecretion/surgery
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1802
[Cu] Class update date: 180209
[Lr] Last revision date:180209
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:180201
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009455


page 1 of 2486 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information